AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18360012 — intervention group
Group type: COMPARATOR
Intervention: Telmisartan (40 mg/day)
Number of subjects: 20
Study 16102606 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine EUS-FNA
Number of subjects: 104
Study 16102606 — intervention group
Group type: COMPARATOR
Intervention: Conventional workup (CWU)
Number of subjects: 104
Study 12059931 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermin
Number of subjects: 160
Study 12059931 — intervention group
Group type: EXPERIMENTAL
Intervention: Caviton
Number of subjects: 160
Study 12059931 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavit
Number of subjects: 160
Study 12059931 — intervention group
Group type: EXPERIMENTAL
Intervention: Canseal (two groups tested)
Number of subjects: 160
Study 10078667 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (6 microg/kg orally 120 min before anesthesia and 3 microg/kg intravenously over 60 min before the end of surgery)
Number of subjects: 20
Study 10078667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 10078667 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 20
Study 7724385 — intervention group
Group type: EXPERIMENTAL
Intervention: Epicardial patch (EPI)
Number of subjects: 67
Study 7724385 — intervention group
Group type: COMPARATOR
Intervention: Nonthoracotomy CPI Endotak (ENDO)
Number of subjects: 67
Study 2187877 — intervention group
Group type: EXPERIMENTAL
Intervention: Active electromagnetic stimulation units
Number of subjects: 45
Study 2187877 — intervention group
Group type: COMPARATOR
Intervention: Dummy control units
Number of subjects: 45
Study 7008711 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 29
Study 7008711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 31264903 — intervention group
Group type: EXPERIMENTAL
Intervention: One rescuer
Number of subjects: 18
Study 31264903 — intervention group
Group type: EXPERIMENTAL
Intervention: Two rescuers
Number of subjects: 18
Study 31264903 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexisting training
Number of subjects: 18
Study 31264903 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning effect
Number of subjects: 18
Study 28465557 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein-enriched egg yolk dairy drink
Number of subjects: 101
Study 28465557 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 101
Study 25395354 — intervention group
Group type: EXPERIMENTAL
Intervention: New oak moss
Number of subjects: 60
Study 25395354 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic oak moss
Number of subjects: 60
Study 25395354 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (non-allergic)
Number of subjects: 60
Study 23958945 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 202
Study 23958945 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 202
Study 23958945 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 202
Study 23958945 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 202
Study 23184900 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU of oral ergocalciferol weekly for 12 weeks
Number of subjects: 90
Study 23184900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 19914548 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole monotherapy
Number of subjects: 0
Study 19914548 — intervention group
Group type: COMPARATOR
Intervention: Sequential treatment arms
Number of subjects: 0
Study 19914548 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole initiation
Number of subjects: 0
Study 19914548 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole followed by Tamoxifen
Number of subjects: 0
Study 18184078 — intervention group
Group type: EXPERIMENTAL
Intervention: ddI + 1000 mg HU
Number of subjects: 69
Study 18184078 — intervention group
Group type: EXPERIMENTAL
Intervention: ddI + 1500 mg HU
Number of subjects: 69
Study 18184078 — intervention group
Group type: COMPARATOR
Intervention: HU monotherapy
Number of subjects: 69
Study 15700852 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine (1,000 mg/m2 intravenously weekly for 7 weeks, followed by 1 week of rest, then weekly for 3 weeks every 4 weeks)
Number of subjects: 138
Study 15700852 — intervention group
Group type: EXPERIMENTAL
Intervention: FLEC (5-fluorouracil 1,000 mg/m2, leucovorin 100 mg/m2, epirubicin 60 mg/m2, carboplatin 300 mg/m2 infused intra-arterially at a 3-week interval 3 times or 5-fluorouracil 400 mg/m2 plus folinic acid 20 mg/m2 for 5 days every 4 weeks for 6 cycles)
Number of subjects: 138
Study 11240079 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior-oriented physical therapy (PT)
Number of subjects: 0
Study 11240079 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 0
Study 11240079 — intervention group
Group type: EXPERIMENTAL
Intervention: BM rehabilitation (PT+CBT)
Number of subjects: 0
Study 11240079 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (CG)
Number of subjects: 0
Study 9855165 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss and treatment with acetazolamide during a 24‐week period
Number of subjects: 15
Study 9855165 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss of 6.2%
Number of subjects: 15
Study 9855165 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 15
Study 9855165 — intervention group
Group type: COMPARATOR
Intervention: No weight loss
Number of subjects: 15
Study 8033506 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (5 mg)
Number of subjects: 11
Study 8033506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 2728087 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian dosing program for phenytoin
Number of subjects: 40
Study 2728087 — intervention group
Group type: COMPARATOR
Intervention: Group of physicians
Number of subjects: 40
Study 4157355 — intervention group
Group type: COMPARATOR
Intervention: Aqueous procaine penicillin G (2,400,000 U for men; 2,400,000 U daily for 2 days for women)
Number of subjects: 334
Study 4157355 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectinomycin hydrochloride (2.0 g for men; 4.0 g for women)
Number of subjects: 334
Study 31587569 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA)
Number of subjects: 32
Study 31587569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 31156245 — intervention group
Group type: EXPERIMENTAL
Intervention: teberif
Number of subjects: 0
Study 31156245 — intervention group
Group type: COMPARATOR
Intervention: rebif
Number of subjects: 0
Study 31156245 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 27935182 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (training measures for nursing staff and treating physicians)
Number of subjects: 195
Study 27935182 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 195
Study 25554757 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot intervention (immunization records obtained, immunization status determined, catch-up doses administered before discharge)
Number of subjects: 356
Study 22519565 — intervention group
Group type: EXPERIMENTAL
Intervention: Single planning intervention
Number of subjects: 373
Study 22519565 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 weeks' repeated planning intervention
Number of subjects: 373
Study 22519565 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks' repeated planning intervention
Number of subjects: 373
Study 22519565 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 weeks' repeated planning intervention
Number of subjects: 373
Study 22519565 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 373
Study 20685179 — intervention group
Group type: COMPARATOR
Intervention: 9 Gy per fraction in two fractions (Control Arm A)
Number of subjects: 104
Study 20685179 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.8 Gy per fraction in 3 fractions (Study Arm B)
Number of subjects: 104
Study 19168553 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose MDMA (1.0 mg/kg)
Number of subjects: 15
Study 19168553 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose MDMA (1.6 mg/kg)
Number of subjects: 15
Study 19168553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 16505498 — intervention group
Group type: EXPERIMENTAL
Intervention: Benfluorex 450 mg/day
Number of subjects: 325
Study 16505498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 325
Study 15807102 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferential electric current stimulation at frequencies deltaf of 10 Hz, 30 Hz, 50 Hz, and 100 Hz.
Number of subjects: 6
Study 11593350 — intervention group
Group type: EXPERIMENTAL
Intervention: Black tea (5 cups/day for 4 weeks)
Number of subjects: 22
Study 11593350 — intervention group
Group type: COMPARATOR
Intervention: Hot water (5 cups/day for 4 weeks)
Number of subjects: 22
Study 9844331 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusion therapy
Number of subjects: 0
Study 9844331 — intervention group
Group type: COMPARATOR
Intervention: Control eyes
Number of subjects: 0
Study 7990479 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Ftorafur (10 mg/kg daily)
Number of subjects: 115
Study 7990479 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 115
Study 7990479 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Ftorafur
Number of subjects: 115
Study 3058455 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 12
Study 3058455 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.50 mg
Number of subjects: 12
Study 3058455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31104111 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitizing gel applied for 10 min before bleaching with 35% hydrogen peroxide, followed by placebo gel after.
Number of subjects: 180
Study 31104111 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitizing gel applied for 10 min before and after bleaching procedure.
Number of subjects: 180
Study 31104111 — intervention group
Group type: COMPARATOR
Intervention: Both groups (desensitizing gel before and before & after)
Number of subjects: 180
Study 30454075 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention involving changes to the birthing room to encourage an upright position and mobility during labour.
Number of subjects: 3800
Study 30454075 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard birthing room environment).
Number of subjects: 3800
Study 30454075 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention.
Number of subjects: 3800
Study 28462761 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced cleaning intervention with monitoring and feedback to EVS and infection control staff.
Number of subjects: 15
Study 28462761 — intervention group
Group type: COMPARATOR
Intervention: Standard cleaning (control group).
Number of subjects: 15
Study 26358534 — intervention group
Group type: EXPERIMENTAL
Intervention: Collective efficacy enhanced intervention
Number of subjects: 0
Study 26358534 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention
Number of subjects: 0
Study 23360676 — intervention group
Group type: EXPERIMENTAL
Intervention: Special carbohydrate-whey protein cake (3.5:1 ratio)
Number of subjects: 9
Study 23360676 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric carbohydrate cake (control)
Number of subjects: 9
Study 22013799 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiezhuo Chubi Recipe (XCR)
Number of subjects: 99
Study 22013799 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzbromarone Tablet (50 mg, once per day)
Number of subjects: 99
Study 22013799 — intervention group
Group type: COMPARATOR
Intervention: Blank control group (no treatment)
Number of subjects: 99
Study 18583433 — intervention group
Group type: EXPERIMENTAL
Intervention: delta‐9‐tetrahydrocannabinol (THC)
Number of subjects: 0
Study 14651539 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium (BPS), 7 patients (PG group)
Number of subjects: 20
Study 14651539 — intervention group
Group type: COMPARATOR
Intervention: Control group, 13 patients
Number of subjects: 20
Study 10468028 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose 20 mls tds (increasing water content)
Number of subjects: 16
Study 10468028 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine 30 gms qds (decreasing water content)
Number of subjects: 16
Study 10468028 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 16
Study 8557066 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF‐I (80 micrograms kg‐1 bw) subcutaneously twice daily
Number of subjects: 30
Study 8557066 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 30
Study 8557066 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF‐I (100 micrograms kg‐1) in mice
Number of subjects: 30
Study 8557066 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF‐I (1 microgram mL‐1) in vitro
Number of subjects: 30
Study 2172885 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate at a dose of 160 mg/day
Number of subjects: 40
Study 2172885 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate at a dose of 480 mg/day
Number of subjects: 40
Study 582982 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 microgram/day p.o.) for 2 days in healthy volunteers
Number of subjects: 39
Study 582982 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 microgram/day p.o.) for 2 weeks in patients with intractable angina
Number of subjects: 39
Study 31800496 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative treatment with antibiotics
Number of subjects: 50
Study 31800496 — intervention group
Group type: COMPARATOR
Intervention: Appendectomy
Number of subjects: 50
Study 30698038 — intervention group
Group type: EXPERIMENTAL
Intervention: LBBB
Number of subjects: 784
Study 30698038 — intervention group
Group type: COMPARATOR
Intervention: No LBBB
Number of subjects: 784
Study 28279659 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive rehabilitation protocol (2 sessions a day)
Number of subjects: 40
Study 28279659 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment (1 session a day)
Number of subjects: 40
Study 25920649 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted TKA
Number of subjects: 90
Study 25920649 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA using an intramedullary guide
Number of subjects: 90
Study 25920649 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA using an extramedullary guide
Number of subjects: 90
Study 24086732 — intervention group
Group type: EXPERIMENTAL
Intervention: BPSL training
Number of subjects: 94
Study 24086732 — intervention group
Group type: COMPARATOR
Intervention: TRAD teaching
Number of subjects: 94
Study 21851907 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary bone marrow mononuclear cells (BMMC)
Number of subjects: 60
Study 21851907 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary peripheral blood mononuclear cells (PBMC)
Number of subjects: 60
Study 21851907 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 19495945 — intervention group
Group type: EXPERIMENTAL
Intervention: One-time verbal counseling, educational material, reminder aids and follow-up
Number of subjects: 203
Study 19495945 — intervention group
Group type: COMPARATOR
Intervention: No organized follow-up or counseling
Number of subjects: 203
Study 17240120 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg or 20 mg)
Number of subjects: 468
Study 17240120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 468
Study 15524059 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10-40 mg daily
Number of subjects: 42
Study 15524059 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 42
Study 15524059 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 and 40 mg daily
Number of subjects: 42
Study 11878728 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% articaine with 1:200,000 epinephrine
Number of subjects: 82
Study 11878728 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine and 2% lidocaine
Number of subjects: 82
Study 9625834 — intervention group
Group type: EXPERIMENTAL
Intervention: Ki-67 index measurement
Number of subjects: 130
Study 9625834 — intervention group
Group type: EXPERIMENTAL
Intervention: Ki-67 index in differentiated carcinomas
Number of subjects: 130
Study 9625834 — intervention group
Group type: EXPERIMENTAL
Intervention: Ki-67 index in undifferentiated tumors
Number of subjects: 130
Study 9625834 — intervention group
Group type: EXPERIMENTAL
Intervention: High Ki-67 index (55%)
Number of subjects: 130
Study 7930780 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous secretin injection
Number of subjects: 159
Study 7930780 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonographic secretin test
Number of subjects: 159
Study 30358724 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen plus progestogen therapy (EPT) - 0.625 mg conjugated equine estrogens plus 2.5 mg medroxyprogesterone acetate
Number of subjects: 2763
Study 30358724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2763
Study 29873468 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anaesthesia
Number of subjects: 2
Study 29873468 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane anaesthesia
Number of subjects: 2
Study 23640912 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention (IT)
Number of subjects: 1685
Study 23640912 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal counseling (PC)
Number of subjects: 1685
Study 23640912 — intervention group
Group type: COMPARATOR
Intervention: Self-directed control (SD)
Number of subjects: 1685
Study 23301471 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint embedding therapy
Number of subjects: 218
Study 23301471 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 218
Study 20549558 — intervention group
Group type: EXPERIMENTAL
Intervention: Case manager delivered HIV prevention intervention
Number of subjects: 25
Study 20549558 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental case managers
Number of subjects: 25
Study 19571077 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine infusion at 5 mL/hr
Number of subjects: 158
Study 19571077 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 158
Study 19571077 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine infusion
Number of subjects: 158
Study 19571077 — intervention group
Group type: COMPARATOR
Intervention: 0.75% ropivacaine infusion and Placebo
Number of subjects: 158
Study 16624769 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B12 mixed solution inhalation
Number of subjects: 122
Study 16624769 — intervention group
Group type: COMPARATOR
Intervention: Gentamycin sulfate mixed solution inhalation
Number of subjects: 122
Study 15010338 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin levels in cirrhosis
Number of subjects: 20
Study 11156116 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative duplex scanning of the carotid artery, computed tomography of the chest, and intraoperative ultrasonography of the ascending aorta.
Number of subjects: 308
Study 11156116 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative parameters analyzed through screening.
Number of subjects: 308
Study 11156116 — intervention group
Group type: EXPERIMENTAL
Intervention: Modifications on the operative procedure for aortic atherosclerosis.
Number of subjects: 308
Study 11156116 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall hospital mortality and morbidity for stroke.
Number of subjects: 308
Study 9252829 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain killers (specific types not mentioned)
Number of subjects: 0
Study 9252829 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 8277057 — intervention group
Group type: EXPERIMENTAL
Intervention: Luting agents with resin restorative systems
Number of subjects: 0
Study 8277057 — intervention group
Group type: EXPERIMENTAL
Intervention: Luting agents with ceramic restorative systems
Number of subjects: 0
Study 8277057 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 3828603 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained hairdressers
Number of subjects: 15
Study 3828603 — intervention group
Group type: COMPARATOR
Intervention: Untrained hairdressers
Number of subjects: 15
Study 29952648 — intervention group
Group type: EXPERIMENTAL
Intervention: Orotracheal intubation
Number of subjects: 26
Study 29952648 — intervention group
Group type: COMPARATOR
Intervention: Nasotracheal intubation
Number of subjects: 26
Study 26864920 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 24
Study 26864920 — intervention group
Group type: COMPARATOR
Intervention: Trifluoperazine
Number of subjects: 24
Study 24108307 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan/naproxen sodium
Number of subjects: 443
Study 24108307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 443
Study 22858285 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoriasis patients
Number of subjects: 122
Study 22858285 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients without psoriasis, n = 134)
Number of subjects: 122
Study 20572863 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in self-reported toothbrushing frequency
Number of subjects: 1362
Study 20572863 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in knowledge and attitudes related to oral health
Number of subjects: 1362
Study 20572863 — intervention group
Group type: EXPERIMENTAL
Intervention: Associations between changes in toothbrushing frequency and knowledge/attitudes
Number of subjects: 1362
Study 18721518 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 to 4 drinks/week
Number of subjects: 5153